Rezolute, Inc.
Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibod…
Biotechnology
US, Redwood City [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Rezolute, Inc. has no acquisition track records yet.
M&A Deals · History
Rezolute, Inc. has no acquisition track records yet.